March 25, 2025

Most Pediatric Valve Implants Used Off-Label

Fewer than 10% of cardiac valve devices implanted in U.S. pediatric patients were FDA approved for children.

Conexiant

March 24, 2025

Cannabis Use: Multicenter Study Links to Increased MI, Stroke Risks

Cannabis use associated with over sixfold higher risk of myocardial infarction in otherwise healthy adults, according to new multicenter study.

Conexiant

March 21, 2025

Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy

The FDA approves vutrisiran (Amvuttra) as the first RNAi therapeutic to reduce cardiovascular events and mortality in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 19, 2025

Passive Heat Therapy Improves Heart Failure Mobility

A randomized trial found that heating the lower limbs increased exercise endurance in heart failure patients, with blood flow rising significantly after treatment.

Conexiant

March 18, 2025

30-Month Study Tracks Post-COVID Health Risks

In a new study on the long-term health risks post–COVID-19 hospitalization, researchers reported an "increased risk of death or hospitalization for various organ disorders up to 30 months after discharge."

Conexiant

March 18, 2025

Lipid Changes Post-Ivacaftor in Cystic Fibrosis

Cholesterol levels in cystic fibrosis patients were found to increase within 3 months of starting ivacaftor therapy, then returned to baseline by 18 months.

Conexiant

March 14, 2025

Maternal Health Trajectories: CVD Risks Start Before Pregnancy

Women with adverse pregnancy outcomes had higher BMI, BP, and glucose 10 years before pregnancy and persistently elevated risks up to 15 years postpartum, a new cohort study finds.

Conexiant

March 14, 2025

Reduced-Dose Anticoagulants Lower Bleeding, Study Finds

Findings indicate that while non-inferiority was not established, the reduced-dose regimen resulted in fewer bleeding complications without a marked increase in venous thromboembolism (VTE) recurrence.

Conexiant